Search

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before having a transplant appear to be at higher risk for developing complications. These findings further support evidence that the connection between microbiota and outcomes starts before people begin the transplantation process. These findings were presented as part of the 2018 annual meeting of the American Society of Hematology (ASH) press program.

… Sunday, December 2, 2018 Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower gut microbiota diversity before

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.

… Tuesday, July 12, 2022 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have used DNA testing and other methods to identify a previously uncharacterized subtype of small cell lung cancer (SCLC) . As they report in a study published July 6, 2022 , in the journal Clinical Cancer Research , the

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.

… Friday, October 1, 2010 Summary A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer. A team of clinicians and computational biologists have compiled the largest catalog to date of genetic

A new pilot study by investigators at Memorial Sloan Kettering Cancer Center found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

… Thursday, March 6, 2008 A new pilot study by investigators at Memorial Sloan Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown

MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry.

… Friday, August 27, 2021 Forbes has named MSK one of America’s Best-In-State Employers 2021 . MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry. Earlier this year, Forbes ranked MSK #17 on its list of America’s Best Employers for

Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves.

… Thursday, June 13, 2024 Today Sammy C. is a healthy 16-year-old boy — a top varsity athlete who plays three sports. But only 18 months ago, his life was very different. Sammy was dealing with a neuroendocrine tumor , a rare and aggressive cancer, in the lower part of his colon. He and his family sought

Some children enjoy playing with blocks, dolls, and toy cars. Dr. Ying Liu, a gynecologic medical oncologist and attending in the Clinical Genetics Service at Memorial Sloan Kettering, was fascinated by the test tubes in her mother’s laboratory. Dr. Liu didn’t know it then, but holding those sleek glass cylinders was the same as looking into a crystal ball.

… Tuesday, May 31, 2022 Some children enjoy playing with blocks, dolls, and toy cars. Dr. Ying Liu , a gynecologic medical oncologist and attending in the Clinical Genetics Service at Memorial Sloan Kettering, was fascinated by the test tubes in her mother’s laboratory. Dr. Liu didn’t know it then, but

A multi-institutional study led by Memorial Sloan Kettering Cancer Center (MSKCC) shows that patients whose colorectal cancer has spread to the liver and who received chemotherapy directly to the liver through a pump in the abdomen (an approach called Hepatic Arterial Infusion or HAI) fare better than those who received systemic (intravenously administered) chemotherapy.

… Monday, February 27, 2006 A multi-institutional study led by Memorial Sloan Kettering Cancer Center (MSKCC) shows that patients whose colorectal cancer has spread to the liver and who received chemotherapy directly to the liver through a pump in the abdomen (an approach called Hepatic Arterial Infusion

Almost three-fourths of pediatric cancer survivors will have a chronic health problem within 30 years after the cancer diagnosis, with 40 percent experiencing a serious, life-threatening, disabling, or fatal condition, according to investigators from Memorial Sloan Kettering Cancer Center (MSKCC), St. Jude Children's Research Hospital, and other institutions.

… Wednesday, October 11, 2006 Almost three-fourths of pediatric cancer survivors will have a chronic health problem within 30 years after the cancer diagnosis, with 40 percent experiencing a serious, life-threatening, disabling, or fatal condition, according to investigators from Memorial Sloan Kettering

A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.

… Friday, August 2, 2024 A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients. Invasive fungal infections represent a major cause of infectious illness